Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-13, with 32 holding rows worth $103,621,000.

Accession
0000919574-14-006217
Filed
2014-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 32 entries on the cover page, a total value of $103,621,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $103,623,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROSHARES TR74348A319ULTSHT RUSS2000225,000$11,075,000thousands by filing date
ALBANY MOLECULAR RESH012423109COMMON STOCK498,200$10,995,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM350,000$9,898,000thousands by filing date
ACTAVIS PLCG0083B108SHS30,000$7,238,000thousands by filing date
ACTAVIS PLCG0083B108SHS25,000$6,032,000thousands by filing datecall
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK200,000$5,970,000thousands by filing datecall
Merck & Co.,Inc.58933Y105COM100,000$5,928,000thousands by filing datecall
Pfizer Inc.717081103COM200,000$5,914,000thousands by filing datecall
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR100,000$5,375,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR75,000$5,358,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock77,208$4,685,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR50,000$3,572,000thousands by filing datecall
BARCLAYS IPTH SRS B S&P SHRT TRM ETN06742E711IPATH S&P500 VIX100,000$3,118,000thousands by filing datecall
Pfizer Inc.717081103COM100,000$2,957,000thousands by filing date
Bristol-Myers Squibb Company110122108COM50,000$2,559,000thousands by filing dateput
PROSHARES TR74347B409ULTSH NASD BIOT200,000$2,408,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW50,000$2,350,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM25,000$1,134,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK240,968$1,089,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK400,000$776,000thousands by filing date
ARTIVION INC228903100COM75,000$740,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW100,000$714,000thousands by filing datecall
CEMPRA INC15130J109COM50,000$548,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM100,000$540,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM100,000$540,000thousands by filing datecall
KINDRED BIOSCIENCES INC COM494577109Stock50,000$463,000thousands by filing date
FIBROCELL SCIENCE INC315721209COM NEW157,769$458,000thousands by filing date
SUCAMPO PHARMACEUTICALS-CL A864909106CL A51,630$336,000thousands by filing date
CELSION CORPORATION COM PAR15117N404Stock100,000$296,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM16,464$205,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW25,000$179,000thousands by filing date
ZOGENIX INC98978L105COM150,000$173,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-14-006217this filing2014-11-13acceptance time not in the bulk data set